U.S. flag

An official website of the United States government

NM_000124.4(ERCC6):c.3071-1G>A AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003660823.2

Allele description [Variation Report for NM_000124.4(ERCC6):c.3071-1G>A]

NM_000124.4(ERCC6):c.3071-1G>A

Gene:
ERCC6:ERCC excision repair 6, chromatin remodeling factor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q11.23
Genomic location:
Preferred name:
NM_000124.4(ERCC6):c.3071-1G>A
HGVS:
  • NC_000010.11:g.49470890C>T
  • NG_009442.1:g.73212G>A
  • NM_000124.4:c.3071-1G>AMANE SELECT
  • NM_001346440.2:c.3071-1G>A
  • LRG_465t1:c.3071-1G>A
  • LRG_465:g.73212G>A
  • NC_000010.10:g.50678936C>T
  • NM_000124.2:c.3071-1G>A
Links:
dbSNP: rs1554875287
NCBI 1000 Genomes Browser:
rs1554875287
Molecular consequence:
  • NM_000124.4:c.3071-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001346440.2:c.3071-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Clear Turn Off Turn On
  • Psathyrella gordonii isolate 9186 beta-tubulin gene, partial cds
    Psathyrella gordonii isolate 9186 beta-tubulin gene, partial cds
    gi|678194765|gb|KJ664898.1|
    Nucleotide
  • Ceramides
    Ceramides
    Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl g...<br/>Year introduced: 1972
    MeSH
  • Trihexosylceramides
    Trihexosylceramides
    Glycosphingolipids which contain as their polar head group a trisaccharide (galactose-galactose-glucose) moiety bound in glycosidic linkage to the hydroxyl group of ceramide. ...<br/>Year introduced: 1991(1979)
    MeSH
  • Gangliosides
    Gangliosides
    A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides ar...<br/>
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004376778Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Pathogenic
(Aug 14, 2023) 		germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Cerebro-oculo-facio-skeletal syndrome: three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation.

Laugel V, Dalloz C, Tobias ES, Tolmie JL, Martin-Coignard D, Drouin-Garraud V, Valayannopoulos V, Sarasin A, Dollfus H.

J Med Genet. 2008 Sep;45(9):564-71. doi: 10.1136/jmg.2007.057141. Epub 2008 Jul 15.

PubMed [citation]
PMID:
18628313
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004376778.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change affects an acceptor splice site in intron 17 of the ERCC6 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with Cockayne syndrome (PMID: 33904453). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 551813). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024